Jinyu Total Assets vs Short Term Investments Analysis

600201 Stock   7.32  0.34  4.87%   
Jinyu Bio financial indicator trend analysis is infinitely more than just investigating Jinyu Bio Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jinyu Bio Technology is a good investment. Please check the relationship between Jinyu Bio Total Assets and its Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Assets vs Short Term Investments

Total Assets vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jinyu Bio Technology Total Assets account and Short Term Investments. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Jinyu Bio's Total Assets and Short Term Investments is 0.13. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Jinyu Bio Technology Co, assuming nothing else is changed. The correlation between historical values of Jinyu Bio's Total Assets and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Jinyu Bio Technology Co are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Total Assets i.e., Jinyu Bio's Total Assets and Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.13
Relationship DirectionPositive 
Relationship StrengthInsignificant

Total Assets

Total assets refers to the total amount of Jinyu Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Jinyu Bio Technology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Short Term Investments

Short Term Investments is an item under the current assets section of Jinyu Bio balance sheet. It contains any investments Jinyu Bio Technology Co undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Jinyu Bio Technology can easily liquidate in the marketplace.
Most indicators from Jinyu Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jinyu Bio Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
The current year's Tax Provision is expected to grow to about 62.3 M, whereas Selling General Administrative is forecasted to decline to about 230.1 M.
 2021 2022 2023 2024 (projected)
Operating Income426.3M297.7M324.8M316.5M
Total Revenue1.8B1.5B1.6B1.0B

Jinyu Bio fundamental ratios Correlations

-0.160.591.00.870.980.860.650.950.310.97-0.18-0.380.780.960.980.92-0.910.970.870.940.850.87-0.760.130.8
-0.160.33-0.18-0.28-0.16-0.020.0-0.250.01-0.240.470.250.23-0.3-0.24-0.270.05-0.19-0.34-0.13-0.09-0.190.00.35-0.15
0.590.330.540.370.50.460.550.49-0.030.560.330.00.910.420.540.36-0.610.570.340.60.670.37-0.610.410.33
1.0-0.180.540.850.990.870.680.930.280.96-0.24-0.430.750.960.980.91-0.890.970.850.940.860.86-0.760.150.77
0.87-0.280.370.850.860.690.330.930.550.85-0.05-0.180.650.940.870.93-0.770.860.980.80.570.92-0.49-0.280.95
0.98-0.160.50.990.860.910.640.930.30.95-0.26-0.450.730.960.980.93-0.90.950.860.930.790.88-0.730.110.81
0.86-0.020.460.870.690.910.640.790.230.82-0.33-0.620.730.830.850.81-0.860.880.70.910.680.84-0.70.230.77
0.650.00.550.680.330.640.640.43-0.290.55-0.4-0.580.610.490.560.35-0.490.650.290.630.830.3-0.510.370.29
0.95-0.250.490.930.930.930.790.430.490.95-0.13-0.260.720.980.960.96-0.920.930.960.920.70.93-0.730.00.87
0.310.01-0.030.280.550.30.23-0.290.490.330.260.270.210.450.350.5-0.370.340.580.34-0.010.57-0.17-0.30.59
0.97-0.240.560.960.850.950.820.550.950.33-0.23-0.340.740.950.980.93-0.910.940.880.920.80.88-0.770.110.77
-0.180.470.33-0.24-0.05-0.26-0.33-0.4-0.130.26-0.230.750.19-0.2-0.18-0.150.17-0.21-0.09-0.21-0.25-0.110.19-0.15-0.07
-0.380.250.0-0.43-0.18-0.45-0.62-0.58-0.260.27-0.340.75-0.18-0.37-0.35-0.250.42-0.44-0.19-0.47-0.49-0.280.42-0.36-0.26
0.780.230.910.750.650.730.730.610.720.210.740.19-0.180.680.740.63-0.80.80.610.830.730.68-0.660.260.67
0.96-0.30.420.960.940.960.830.490.980.450.95-0.2-0.370.680.970.97-0.890.960.960.920.740.94-0.68-0.040.88
0.98-0.240.540.980.870.980.850.560.960.350.98-0.18-0.350.740.970.95-0.910.950.890.930.790.89-0.780.130.79
0.92-0.270.360.910.930.930.810.350.960.50.93-0.15-0.250.630.970.95-0.850.890.950.860.60.95-0.65-0.080.87
-0.910.05-0.61-0.89-0.77-0.9-0.86-0.49-0.92-0.37-0.910.170.42-0.8-0.89-0.91-0.85-0.91-0.8-0.95-0.77-0.860.89-0.33-0.77
0.97-0.190.570.970.860.950.880.650.930.340.94-0.21-0.440.80.960.950.89-0.910.870.980.840.9-0.750.130.83
0.87-0.340.340.850.980.860.70.290.960.580.88-0.09-0.190.610.960.890.95-0.80.870.820.560.94-0.54-0.250.93
0.94-0.130.60.940.80.930.910.630.920.340.92-0.21-0.470.830.920.930.86-0.950.980.820.820.89-0.820.250.8
0.85-0.090.670.860.570.790.680.830.7-0.010.8-0.25-0.490.730.740.790.6-0.770.840.560.820.54-0.80.440.46
0.87-0.190.370.860.920.880.840.30.930.570.88-0.11-0.280.680.940.890.95-0.860.90.940.890.54-0.59-0.120.95
-0.760.0-0.61-0.76-0.49-0.73-0.7-0.51-0.73-0.17-0.770.190.42-0.66-0.68-0.78-0.650.89-0.75-0.54-0.82-0.8-0.59-0.67-0.44
0.130.350.410.15-0.280.110.230.370.0-0.30.11-0.15-0.360.26-0.040.13-0.08-0.330.13-0.250.250.44-0.12-0.67-0.26
0.8-0.150.330.770.950.810.770.290.870.590.77-0.07-0.260.670.880.790.87-0.770.830.930.80.460.95-0.44-0.26
Click cells to compare fundamentals

Jinyu Bio Account Relationship Matchups

Jinyu Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets5.6B6.3B6.6B6.4B6.9B7.2B
Other Current Liab156.5M269.2M238.7M194.4M63.6M60.4M
Total Current Liabilities548.0M679.5M689.2M658.7M840.4M604.9M
Total Stockholder Equity4.6B5.0B5.3B5.1B5.4B5.6B
Other Liab153.7M335.8M354.4M380.6M437.7M459.6M
Retained Earnings2.8B3.1B3.4B3.5B3.2B3.3B
Accounts Payable295.2M330.3M347.1M354.4M324.4M176.8M
Cash1.1B1.5B1.3B1.4B1.7B884.3M
Other Assets473.1M447.9M483.2M513.8M590.9M620.5M
Net Receivables643.0M605.6M729.1M763.3M857.5M900.4M
Inventory245.3M350.7M317.7M333.5M322.3M388.8M
Other Current Assets23.2M16.1M19.4M19.8M23.9M35.7M
Total Liab716.8M1.0B1.0B1.0B1.2B720.8M
Intangible Assets519.7M576.7M648.5M668.5M728.8M765.3M
Property Plant Equipment1.6B1.7B1.8B1.8B2.1B2.2B
Net Tangible Assets4.2B4.5B4.8B4.7B5.4B4.4B
Deferred Long Term Liab186.6M238.7M260.2M322.5M370.9M389.5M
Total Current Assets2.7B3.2B2.8B2.7B3.0B3.3B
Non Current Assets Total2.9B3.1B3.8B3.7B3.9B3.1B
Non Currrent Assets Other80.6M160.8M784.6M711.5M621.2M511.3M
Short Term Investments672.5M639.5M183.9M46.9M37.3M35.4M
Non Current Liabilities Total168.8M335.8M354.5M380.9M377.2M275.3M
Other Stockholder Equity133.8K(196.7K)(232.7K)(410.1K)(369.1K)(350.6K)
Net Invested Capital4.7B5.0B5.3B5.1B5.4B5.5B
Net Working Capital2.1B2.5B2.1B2.0B2.2B1.9B
Good Will130.8M134.3M94.5M29.5M11.4M10.8M

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

Balance Sheet is a snapshot of the financial position of Jinyu Bio Technology at a specified time, usually calculated after every quarter, six months, or one year. Jinyu Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jinyu Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jinyu currently owns. An asset can also be divided into two categories, current and non-current.